Why small parcel shipments are a growing priority for contract pharma
Sebastien Pradal, Head of Specialty Sales, Envirotainer
The pharmaceutical industry continues to navigate rapid transformation, driven by innovation in treatment delivery, rising demand for personalized therapies, and growing expectations around supply chain resilience. These expectations include not only ensuring product integrity across increasingly complex distribution channels but also the ability to respond quickly to industry changes, regulatory requirements, and specific delivery requirements.
As therapies become more complex, there is a growing need for precise, flexible logistics - making small parcel shipments essential. Complex therapies often require tightly controlled conditions and handling, which are best supported by smaller, more agile shipment formats. This is especially important for contract development and manufacturing organizations (CDMOs) tasked with managing multiple client needs at pace.
Envirotainer is seeing firsthand how these compact, high-stakes shipments are reshaping expectations around cold chain performance. From products shipped at temperatures below −196 °C, up to +37 °C1, the diversity of today’s temperature requirements is vast.
That’s why leading pharma and CDMO organizations rely on Envirotainer’s validated solutions like CryoSure® LN2, which offers industry-leading ultra-cold performance for up to 35 days, along with its ProofPak platform, purpose-built for small parcel flexibility and compliance.
High stakes in small formats
While commercial-scale bulk shipments still drive much of pharma’s logistics infrastructure, it’s the small parcels that increasingly enable innovation and collaboration. Whether it's delivering a personalized therapy to a clinical trial, or ensuring critical doses reach a patient at home, these shipments demand nothing less than precision, speed, and security. These treatments are often time-sensitive and patient-specific, so any delay or mishandling can compromise efficacy, disrupt care, and lead to costly reshipments or treatment failure.
However, these aren’t just smaller versions of bulk commercial shipments. They come with unique challenges. Supporting direct-to-patient delivery and global clinical trials, they involve more handovers, specialized couriers, and complex routes, raising the risk of delays and handling errors. With strict temperature tolerances, the margin for error is virtually zero as even slight deviations can leave a product unusable.
Innovations like Phase Change Materials (PCMs) and Vacuum Insulated Panels (VIPs) help maintain consistent internal conditions, protecting products from external shocks in transit. Purpose-built systems like ProofPak are engineered specifically for this reason, offering unparalleled reliability and risk mitigation. Designed to reduce handling time and the potential for human error, ProofPak also meets global GDP requirements and supports compliance across a range of regulatory environments.
For contract development and manufacturing organizations (CDMOs) under pressure to deliver across varying client requirements, these packaging solutions help ensure service quality while maintaining efficiency.
Flexibility, efficiency and sustainability
Contract pharma providers are under pressure to be more agile, flexible and sustainable than ever. They must be able to scale operations and maintain compliance across different regulatory environments. That’s where Envirotainer brings unique value. With a global footprint covering 3,300 trade lanes and spanning key pharma hubs across Europe, North America, Asia, and the Middle East, an industry-leading R&D centre in Sweden, and 40 years of specialized cold chain expertise, Envirotainer empowers CDMOs to optimize performance and reliability across every shipment size, from small clinical trial shipments to large-scale commercial distributions .Sustainability is just as important, and with the rise in demand for small parcel shipments, they must not come at the cost of environmental progress. That’s why Envirotainer is investing in reusable parcel systems that dramatically reduce packaging waste and carbon emissions2. Envirotainer’s high-performance packaging not only protects the stability and efficacy of medicines but also aligns with ESG goals - something partners and customers are increasingly valuing. By minimizing temperature excursions and preventing product loss, they also reduce the need for re-shipments, supporting cost-efficiency and environmental targets simultaneously.
For routes where return logistics are not feasible, for example, due to remote locations, , advanced single-use options still offer strong protection, ensuring that vital medicines reach even the most inaccessible areas without compromising product efficacy.. Ultimately, smarter packaging choices play a key role in building more resilient and responsible pharmaceutical supply chains.
The future of the cold-chain
With the continued rise of advanced therapies and direct-to-patient models, the strategic role of small parcels will only grow. But success in this space requires more than just packaging, it takes a collaborative approach.
For contract pharma organisations, where the diversity of client needs is the norm, the ability to scale high-performing, compliant packaging quickly is often seen as a competitive advantage. But, real success depends on building partnerships across the supply chain, sharing insights, and investing in solutions that meet both current and future demands.
Envirotainer is proud to partner with forward-thinking pharma companies and contract pharma organizations to build smarter, more resilient cold chain strategies. From ultra-cold biologics to ambient therapies, our solutions are designed to safeguard product integrity, support regulatory compliance, and drive operational efficiency.
Because in today’s pharmaceutical supply chain, the smallest shipments can carry the greatest impact.
References:
1. The four forces shaping pharma cold chain
2. Our Sustainability Reports
Author Bio
Sebastien Pradal, Head of Specialty Sales, Envirotainer
